Page last updated: 2024-08-26

fibrinogen and Thromboembolism, Venous

fibrinogen has been researched along with Thromboembolism, Venous in 79 studies

Research

Studies (79)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	8 (10.13)	29.6817
2010's	48 (60.76)	24.3611
2020's	23 (29.11)	2.80

Authors

Authors	Studies
Franchini, S; Marcianò, T	1
Argyrou, S; Dreden, PV; Gerotziafas, G; Glantzounis, G; Karakosta, A; Lefkou, E; Pantazi, D; Papapetrou, E; Stratigopoulou, P; Tselepis, A; Tzimas, P	1
Bos, MHA; Cannegieter, SC; Lisman, T; Nelissen, RGHH; Nemeth, B; Rondon, AMR; Schipper, IB; Touw, CE; van Adrichem, RA; Versteeg, HH	1
Sang, Y; Wolberg, AS	1
DeSancho, MT; Dev, H; Lane, EG; Margolis, DJ; Prince, MR	1
Albertsen, BK; Andersson, NG; Hoffmann, M; Huurre, A; Jarvis, KB; Joelsson, J; Långström, S; Lohi, O; Mølle, I; Overgaard, U; Ranta, S; Rathe, M; Saulyte Trakymiene, S; Vepsäläinen, K; Vogt, H	1
Alfredsson, L; Askling, J; Bang, H; Cornillet, M; Grönwall, C; Hansson, M; Holmdahl, R; Kastbom, A; Klareskog, L; Lundberg, K; Mathsson-Alm, L; Rönnelid, J; Saevarsdottir, S; Serre, G; Skriner, K; Westerlind, H	1
Andreev, SS; Neymark, BA; Tityaev, II; Vasilenko, AA	1
Bégin, E; Bouchard, V; Bouhêlier, È; Monagle, P; Pelland-Marcotte, MC; Santiago, R	1
Butt, AL; Mazzeffi, MA; McNeil, JS; Tanaka, KA; Terada, R	1
Jiao, Y; Mu, X	1
Brækkan, SK; Frazer, KA; Gabrielsen, ME; Gran, OV; Hansen, JB; Hveem, K; Paulsen, B; Rosendaal, FR; Skille, H; Smith, EN	1
Chou, WY; Ko, JY; Kuo, SJ; Siu, KK; Wang, CJ; Wang, FS; Wu, KT	1
Huang, H; Li, D; Zhang, H; Zhang, X	1
Balsat, M; Boissel, N; Bonmati, C; Cacheux, V; Caillot, D; Chalandon, Y; Chantepie, S; Chevallier, P; de Gunzburg, N; Dombret, H; Frayfer, J; Huguet, F; Hunault-Berger, M; Ifrah, N; Lheritier, V; Marolleau, JP; Orvain, C; Pabst, T; Tavernier, E	1
Caneva, L; Civardi, L; Mojoli, F; Mongodi, S; Tavazzi, G	1
Chiba, M; Fujino, T; Hamada, A; Koga, T; Mitsudomi, T; Nishino, M; Ohara, S; Sato, K; Shimoji, M; Soh, J; Suda, K; Takemoto, T; Tomizawa, K	1
Arter, WE; Chevassut, T; Eziefula, AC; Ladikou, EE; Milne, KM; Philips, B; Ramasamy, R; Saad, R; Sivaloganathan, H; Stoneham, SM	1
Baron, RM; Chen, EC; Cheng, V; Cho, MH; Connell, NT; Connors, JM; Fredenburgh, LE; Moll, M; Sylvester, KW; Woolley, AE; Zon, RL	1
Bonnin, P; Chousterman, BG; Delrue, M; Deye, N; Ketfi, C; Malissin, I; Mebazaa, A; Mégarbane, B; Neuwirth, M; Siguret, V; Stépanian, A; Voicu, S	1
Eljilany, I; Elzouki, AN	1
Boerwinkle, E; de Maat, MPM; de Vries, PS; Debette, S; Dehghan, A; Dichgans, M; Fornage, M; Gill, D; Laffan, MA; Ligthart, S; Maners, J; McKnight, B; Morrison, AC; Pankratz, N; Smith, NL; Tang, W; Ward-Caviness, CK; Wolberg, AS	1
Allison, MA; Cushman, M; Evensen, LH; Folsom, AR; Hansen, JB; Lutsey, PL; Pankow, JS	1
Alvarez-Sala-Walther, L; Del-Toro-Cervera, J; Demelo-Rodríguez, P; Galeano-Valle, F; Oblitas, CM; Ordieres-Ortega, L	1
Barrett, NA; Benedetti, G; Breen, KA; Camporota, L; Doyle, AJ; Hunt, BJ; Mak, SM; Retter, A; Sanderson, B; Zhang, J	1
Jiang, J; Jiao, Y; Liu, K; Ma, H; Yang, H; Zhang, X; Zou, J	1
Hu, L; Liu, R; Wang, R; Xu, D; Zhao, L	1
Barcellona, D; Cianchetti, E; Mameli, A; Mandas, A; Marongiu, F; Porru, M; Ruberto, MF	1
Braekkan, SK; Frazer, KA; Hansen, JB; Hindberg, K; Horvei, LD; Rosendaal, FR; Smith, EN; Solomon, T	1
Wolberg, AS	1
Fidalgo, T; Manco, L; Martinho, P; Ribeiro, ML; Sarmento, AB; Silva, C	1
Greinacher, A; Hunt, BJ; Samama, CM; Thomas, W	1
Feng, B; Gao, N; Jin, J; Lin, J; Qian, WW; Qiu, GX; Weng, XS; Xia, ZN; Xiao, K; Zhang, BZ; Zhu, W	1
Braekkan, SK; Evensen, LH; Gabrielsen, ME; Hansen, JB; Hveem, K; Mathiesen, EB; Morelli, VM; Njølstad, I; Rinde, LB; Rosendaal, FR; Småbrekke, B	1
Antovic, JP; Bremme, K; Holmström, M; Lärfars, G; Rosing, J; Sonnevi, K; Tchaikovski, SN	1
Belaj, K; Brodmann, M; Bruckenberger, R; Froehlich, H; Gary, T; Hackl, G; Hafner, F; Pilger, E; Zebisch, A	1
Bresser, P; Gerdes, VE; Meijers, JC; Oduber, CE; van Beers, EJ; van der Horst, CM	1
Bandinelli, S; Basu, S; Baumert, J; Becker, DM; Becker, LC; Bevan, S; Bis, JC; Boerwinkle, E; Boomsma, DI; Buckley, BM; Campbell, H; Chambers, JC; Chasman, D; Chen, MH; Clarke, R; Cucca, F; Curb, JD; Danesh, J; Davies, G; de Geus, EJ; Deary, IJ; Dehghan, A; Dichgans, M; Eaton, CB; Erdmann, J; Eriksson, JG; Eriksson, P; Ferrucci, L; Folkersen, L; Folsom, AR; Fornage, M; Franco, OH; Franco-Cereceda, A; Franzosi, MG; Gieger, C; Goel, A; Grant, PJ; Green, D; Gross, M; Grotevendt, A; Guo, X; Hamsten, A; Haritunians, T; Harris, SE; Hayward, C; Hofman, A; Homuth, G; Hopewell, JC; Hottenga, JJ; Huang, J; Huffman, JE; Ikram, MA; Illig, T; Jacobs, D; Johnson, AD; Jukema, JW; Kathiresan, S; Kocher, T; Koenig, W; Kolcic, I; Kooner, JS; Lahti, J; Liewald, DC; Liu, S; Lopez, LM; Lowe, GD; Lumley, T; Mälarstig, A; Markus, HS; McArdle, WL; McKnight, B; Mehra, R; Morange, PE; Mosley, TH; Naitza, S; Navarro, P; Nelson, CP; O'Donnell, CJ; Oudot-Mellakh, T; Palotie, A; Peters, A; Polasek, O; Psaty, BM; Pulanic, D; Räikkönen, K; Redline, S; Reilly, MP; Reiner, AP; Ridker, PM; Rivadeneira, F; Rose, LM; Rothwell, PM; Rotter, JI; Rudan, I; Rudnicka, AR; Rumley, A; Sabater-Lleal, M; Saleheen, D; Samani, NJ; Sanna, S; Sattar, N; Schlessinger, D; Schunkert, H; Seedorf, U; Sennblad, B; Seshadri, S; Shin, SY; Silveira, A; Smith, NL; Song, J; Soranzo, N; Spector, TD; Starr, JM; Steri, M; Stott, DJ; Strachan, DP; Strawbridge, RJ; Sudlow, CL; Swords Jenny, N; Tanaka, T; Tang, W; Tarasov, KV; Taylor, KD; Teichert, M; Teumer, A; Tofler, GH; Tracy, RP; Tregouet, D; Trompet, S; Uitterlinden, AG; van Dongen, J; Völzke, H; Wallace, R; Wallaschofski, H; Watkins, H; Widen, E; Wild, SH; Willemsen, G; Williams, FM; Wilson, JF; Witteman, JC; Wright, AF; Yanek, LR; Yao, J; Zemunik, T	1
Kremer, LC; Schoot, RA; van de Wetering, MD; van Ommen, CH	1
Liu, FF; Wang, C; Wang, J; Yang, YH; Zhai, ZG	1
Hilhorst, M; ten Cate, H; Tervaert, JW; van Oerle, R; Wilde, B; Winckers, K	1
Banerjee, A; Chin, TL; Ghasabyan, A; Gonzalez, E; Harr, JN; Moore, EE; Sauaia, A; Silliman, CC; Wohlauer, MV	1
Gao, CT; Hao, JH; Jin, P; Liu, Y; Luo, L; Ma, WD; Ren, H; Sun, W	1
Cini, M; Cosmi, B; Frascaro, M; Legnani, C; Palareti, G; Sartori, M	1
Asanuma, K; Kamimoto, Y; Katayama, N; Matsumoto, T; Mizuno, T; Nomura, H; Ohishi, K; Saito, K; Usui, M; Wada, H; Yamada, N; Yamashita, Y	1
Austin, HD; Hooper, WC; Lally, C; Miller, CH; Payne, AB	1
Hao, J; Liu, C; Liu, X; Man, YN; Wang, YN; Wu, XZ; Zhu, C	1
Abudureheman, K; Hu, X; Mahemuti, A; Tang, B; Upur, H; Xia, Y; Yadav, U	1
Favaloro, EJ; Lippi, G; Simundic, AM; Tripodi, A	1
Davidson, SJ; Davies, NA; Evans, PA; Evans, VJ; Harrison, NK; Hawkins, K; Lawrence, MJ; Morris, RH; Noble, S; Sabra, A; Williams, PR	1
Graziadio, C; Grossman, AB; Isidori, AM; Minnetti, M; Sbardella, E	1
Kato, F; Kawakubo, H; Kitagawa, Y; Matsuda, S; Omori, T; Takeuchi, H	1
Dronkers, CE; Huisman, MV; Klok, FA; van der Hulle, T	1
Anglés-Cano, E; Boada, C; Bueno, SR; Carrerra, C; Delgado, P; Fernández-Cadenas, I; Monasterio, J; Montaner, J; Penalba, A; Quiroga, A	1
Ay, C; Kaider, A; Marosi, C; Pabinger, I; Quehenberger, P; Reitter, EM; Zielinski, C	1
Berens, C; Hertfelder, HJ; Ivaškevičius, V; Oldenburg, J; Pötzsch, B; Rühl, H	1
Agopian, V; Emuakhagbon, V; Jones, CM; Kaldas, FM; Philips, P	1
Asanuma, K; Fujimoto, N; Hasegawa, M; Ito, M; Katayama, N; Matsumoto, T; Miyazaki, S; Ohishi, K; Sakaguchi, A; Sudo, A; Wada, H; Wakabayashi, H; Yamada, N; Yamaguchi, T; Yamashita, Y	1
Cushman, M; Folsom, AR; George, KM; Heckbert, SR; MacLehose, RF; Pankow, JS; Tang, W	1
Akamatsu, Y; Aratake, M; Ishigatsubo, R; Kobayashi, A; Kobayashi, H; Kumagai, K; Kusayama, Y; Mitsuhashi, S; Saito, T	1
Bryk, A; Kościelniak, B; Lech, M; Undas, A	1
Fernandes, T; Morris, T; Planquette, B; Sanchez, O	1
Alessandrini, F; Brandimarti, F; Catalani, C; De Angelis, L; Galeazzi, R; Gesuita, R; Giorgetti, R; Giovagnetti, S; Pesaresi, M; Righi, E; Tagliabracci, A	1
Fujimoto, N; Hasegawa, M; Ito, M; Katayama, N; Matsumoto, T; Miyazaki, S; Nakatani, K; Ohishi, K; Sakaguchi, A; Sudo, A; Wada, H; Wakabayashi, H; Yamada, N; Yamaguchi, T; Yamashita, Y	1
Aya, G; Chauleur, C; Cochery-Nouvellon, E; Gris, JC; Lissalde-Lavigne, G; Marès, P; Mercier, E; Mismetti, P	1
Cushman, M; Folsom, AR; Heckbert, SR; Jacobs, DR; Peacock, JM; Rosamond, WD; Steffen, LM	1
Gohil, R; Peck, G; Sharma, P	1
Ciepłuch, K; Ciesla-Dul, M; Lehmann-Kopydłowska, A; Skubiszak, A; Tracz, W; Undas, A; Zawilska, K	1
Dressler, D; Glowatzki, M; Humpich, M; Lindhoff-Last, E; Luxembourg, B; Schmitt, J; Seifried, E	1
Lang, I	1
Brodde, MF; Kehrel, BE; Nofer, JR	1
Bielis, L; Gadomska, G; Góralczyk, B; Gruszka, M; Odrowąż-Sypniewska, G; Rość, D; Ruszkowska, B	1
Hesse, C; Lindhoff-Last, E; Mani, H; Stratmann, G	1
Ay, C; Dunkler, D; Horvath, B; Mannhalter, C; Pabinger, I; Pabinger, M; Quehenberger, P; Tiedje, V; Zielinski, C	1
Bagnoli, VR; Baracat, EC; D'Amico, EA; Maciel, GA; Maggio da Fonseca, A; Margarido, PF; Soares, JM	1
Cuker, A; Fan, Y; Hazen, SL; Ischiropoulos, H; Lightfoot, R; Martinez, M; Mills, A; Tang, WH	1
Cushman, M; Folsom, AR; Heckbert, SR; Rasmussen-Torvik, LJ; Rosamond, WD; Tsai, MY; Zhang, Y	1
Blouch, MT; Couturaud, F; Delahousse, B; Gruel, Y; Lacut, K; Le Gal, G; Malaviolle, V; Mottier, D; Oger, E; Regina, S	1
Brenner, B; Jacob, G; Masoud, M; Sarig, G	1

Reviews

16 review(s) available for fibrinogen and Thromboembolism, Venous

Article	Year
Fibrinogen and Factor XIII in Venous Thrombosis and Thrombus Stability. Arteriosclerosis, thrombosis, and vascular biology, 2022, Volume: 42, Issue:8 Topics: Blood Coagulation; Factor XIII; Fibrin; Fibrinogen; Hemostatics; Humans; Thrombosis; Venous Thromboembolism; Venous Thrombosis	2022
Biomarkers in pediatric venous thromboembolism: a systematic review of the literature. Journal of thrombosis and haemostasis : JTH, 2023, Volume: 21, Issue:7 Topics: Biomarkers; Child; Child, Preschool; Factor VIII; Fibrinogen; Hemostatics; Humans; Postthrombotic Syndrome; Venous Thromboembolism	2023
Factor VIII: A Dynamic Modulator of Hemostasis and Thrombosis in Trauma. Anesthesia and analgesia, 2023, 05-01, Volume: 136, Issue:5 Topics: Anticoagulants; Factor VIII; Fibrinogen; Fibrinolysin; Hemostasis; Hemostatics; Humans; Inflammation; Thrombin; Thrombosis; Venous Thromboembolism; von Willebrand Factor	2023
Association of β-fibrinogen polymorphisms and venous thromboembolism risk: A PRISMA-compliant meta-analysis. Medicine, 2019, Volume: 98, Issue:48 Topics: Fibrinogen; Humans; Mutation; Polymorphism, Single Nucleotide; Protective Factors; Venous Thromboembolism; White People	2019
D-Dimer, Fibrinogen, and IL-6 in COVID-19 Patients with Suspected Venous Thromboembolism: A Narrative Review. Vascular health and risk management, 2020, Volume: 16 Topics: Anticoagulants; Biomarkers; COVID-19; Fibrin Fibrinogen Degradation Products; Fibrinogen; Heparin, Low-Molecular-Weight; Humans; Incidence; Inflammation Mediators; Interleukin-6; Prevalence; Prognosis; Risk Assessment; Risk Factors; Venous Thromboembolism	2020
Inflammatory Biomarkers in the Short-Term Prognosis of Venous Thromboembolism: A Narrative Review. International journal of molecular sciences, 2021, Mar-05, Volume: 22, Issue:5 Topics: Biomarkers; Blood Sedimentation; C-Reactive Protein; Cytokines; Disease-Free Survival; Female; Fibrinogen; Humans; Inflammation Mediators; Leukocyte Count; Male; P-Selectin; Pulmonary Embolism; Survival Rate; Venous Thromboembolism; Ventricular Dysfunction, Right	2021
Associations between polymorphisms in coagulation-related genes and venous thromboembolism: A meta-analysis with trial sequential analysis. Medicine, 2017, Volume: 96, Issue:13 Topics: Antigens, CD; Antithrombin III; Cytochrome P450 Family 4; Endothelial Protein C Receptor; Factor XI; Fibrinogen; Humans; Platelet Membrane Glycoproteins; Receptors, Cell Surface; Venous Thromboembolism	2017
Fibrinogen and factor XIII: newly recognized roles in venous thrombus formation and composition. Current opinion in hematology, 2018, Volume: 25, Issue:5 Topics: Animals; Blood Coagulation; Erythrocytes; Factor VIII; Fibrinogen; Humans; Venous Thromboembolism; Venous Thrombosis	2018
Multiethnic meta-analysis of genome-wide association studies in >100 000 subjects identifies 23 fibrinogen-associated Loci but no strong evidence of a causal association between circulating fibrinogen and cardiovascular disease. Circulation, 2013, Sep-17, Volume: 128, Issue:12 Topics: Adolescent; Adult; Aged; Aged, 80 and over; Black People; Cardiovascular Diseases; Coronary Artery Disease; Female; Fibrinogen; Genetic Loci; Genetic Predisposition to Disease; Genome-Wide Association Study; Hispanic or Latino; Humans; Male; Middle Aged; Myocardial Infarction; Polymorphism, Single Nucleotide; Risk Factors; Stroke; Venous Thromboembolism; White People; Young Adult	2013
Systemic treatments for the prevention of venous thrombo-embolic events in paediatric cancer patients with tunnelled central venous catheters. The Cochrane database of systematic reviews, 2013, Sep-11, Issue:9 Topics: Anticoagulants; Antithrombins; Central Venous Catheters; Child; Controlled Clinical Trials as Topic; Factor VIII; Fibrinogen; Heparin, Low-Molecular-Weight; Humans; Neoplasms; Plasma; Randomized Controlled Trials as Topic; Venous Thromboembolism; Warfarin	2013
Mechanisms in endocrinology: The spectrum of haemostatic abnormalities in glucocorticoid excess and defect. European journal of endocrinology, 2015, Volume: 173, Issue:3 Topics: Blood Coagulation Disorders; Cushing Syndrome; Factor VIII; Fibrinogen; Glucocorticoids; Humans; Thrombocytosis; Thromboxane B2; Venous Thromboembolism; von Willebrand Factor	2015
Current standings in diagnostic management of acute venous thromboembolism: Still rough around the edges. Blood reviews, 2016, Volume: 30, Issue:1 Topics: Acute Disease; Clinical Decision-Making; Decision Support Techniques; Diagnostic Imaging; Disease Management; Fibrin Fibrinogen Degradation Products; Fibrinogen; Humans; Pulmonary Embolism; Venous Thromboembolism; Venous Thrombosis	2016
From Acute to Chronic Thromboembolic Disease. Annals of the American Thoracic Society, 2016, Volume: 13 Suppl 3 Topics: Acute Disease; Chronic Disease; Endarterectomy; Fibrinogen; Hemodynamics; Humans; Hypertension, Pulmonary; Pulmonary Artery; Pulmonary Embolism; Risk Factors; Thrombolytic Therapy; Vascular Remodeling; Venous Thromboembolism	2016
The genetics of venous thromboembolism. A meta-analysis involving approximately 120,000 cases and 180,000 controls. Thrombosis and haemostasis, 2009, Volume: 102, Issue:2 Topics: Case-Control Studies; Factor V; Factor XIII; Fibrinogen; Genetic Predisposition to Disease; Genetic Variation; Humans; Methylenetetrahydrofolate Reductase (NADPH2); Peptidyl-Dipeptidase A; Plasminogen Activator Inhibitor 1; Polymorphism, Single Nucleotide; Prothrombin; Risk Factors; Venous Thromboembolism	2009
Advances in understanding the pathogenesis of chronic thromboembolic pulmonary hypertension. British journal of haematology, 2010, Volume: 149, Issue:4 Topics: Chronic Disease; Endarterectomy; Fibrinogen; Fibrinolysis; Humans; Hypertension, Pulmonary; Pulmonary Embolism; Venous Thromboembolism	2010
High-density lipoproteins, platelets and the pathogenesis of atherosclerosis. Clinical and experimental pharmacology & physiology, 2010, Volume: 37, Issue:7 Topics: Animals; Atherosclerosis; Biological Transport; Blood Platelets; Cholesterol; Coronary Artery Disease; Coronary Occlusion; Endothelium, Vascular; Female; Fibrinogen; Humans; Lipoproteins, HDL; Male; Mice; Platelet Aggregation; Rabbits; Rats; Venous Thromboembolism	2010

Trials

7 trial(s) available for fibrinogen and Thromboembolism, Venous

Article	Year
Effects of computer-assisted navigation versus the conventional technique for total knee arthroplasty on levels of plasma thrombotic markers: a prospective study. Biomedical engineering online, 2019, Oct-14, Volume: 18, Issue:1 Topics: Aged; Arthroplasty, Replacement, Knee; Biomarkers; Female; Fibrin Fibrinogen Degradation Products; Fibrinogen; Humans; Male; Prospective Studies; Surgery, Computer-Assisted; Venous Thromboembolism	2019
Thromboembolism prophylaxis in adult patients with acute lymphoblastic leukemia treated in the GRAALL-2005 study. Blood, 2020, 07-16, Volume: 136, Issue:3 Topics: Adult; Asparaginase; Female; Fibrinogen; Follow-Up Studies; Heparin; Humans; Incidence; Induction Chemotherapy; Male; Middle Aged; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Venous Thromboembolism	2020
A Mendelian randomization of γ' and total fibrinogen levels in relation to venous thromboembolism and ischemic stroke. Blood, 2020, 12-24, Volume: 136, Issue:26 Topics: Female; Fibrinogen; Genetic Variation; Genome-Wide Association Study; Humans; Ischemic Stroke; Male; Mendelian Randomization Analysis; Risk Factors; Venous Thromboembolism	2020
Postinjury hyperfibrinogenemia compromises efficacy of heparin-based venous thromboembolism prophylaxis. Shock (Augusta, Ga.), 2014, Volume: 41, Issue:1 Topics: Adolescent; Adult; Aged; Anticoagulants; Blood Coagulation; Dose-Response Relationship, Drug; Female; Fibrinogen; Heparin, Low-Molecular-Weight; Humans; Injury Severity Score; Male; Middle Aged; Thrombelastography; Treatment Outcome; Venous Thromboembolism; Wounds and Injuries; Young Adult	2014
The use of factor Xa inhibitors following opening-wedge high tibial osteotomy for venous thromboembolism prophylaxis. Knee surgery, sports traumatology, arthroscopy : official journal of the ESSKA, 2017, Volume: 25, Issue:9 Topics: Aged; Antithrombin III; Factor Xa Inhibitors; Female; Fibrin Fibrinogen Degradation Products; Fibrinogen; Humans; Male; Osteotomy; Peptide Hydrolases; Postoperative Complications; Prospective Studies; Prothrombin Time; Pyridines; Thiazoles; Tibia; Venous Thromboembolism	2017
Risk of venous thromboembolic disease in postmenopausal women taking oral or transdermal hormone replacement therapy. Journal of Zhejiang University. Science. B, 2011, Volume: 12, Issue:1 Topics: Administration, Cutaneous; Administration, Oral; Adult; Antithrombin III; Estrogen Replacement Therapy; Female; Fibrin Fibrinogen Degradation Products; Fibrinogen; Hemostasis; Humans; Lipids; Lipoproteins; Middle Aged; Peptide Hydrolases; Risk Factors; Thromboplastin; Venous Thromboembolism	2011
Transdermal estrogen therapy effects on fibrinogen levels in women with a past history of venous thromboembolism: a pilot study. Clinical and experimental obstetrics & gynecology, 2011, Volume: 38, Issue:3 Topics: Administration, Cutaneous; Adult; Analysis of Variance; Estradiol; Estrogen Replacement Therapy; Estrogens; Female; Fibrinogen; Humans; Middle Aged; Pilot Projects; Thrombelastography; Venous Thromboembolism	2011

Other Studies

56 other study(ies) available for fibrinogen and Thromboembolism, Venous

Article	Year
Could a D-dimer/fibrinogen ratio have a role in ruling-out venous thromboembolism? Emergency medicine journal : EMJ, 2022, Volume: 39, Issue:12 Topics: Fibrin Fibrinogen Degradation Products; Fibrinogen; Humans; Prospective Studies; Pulmonary Embolism; Retrospective Studies; Venous Thromboembolism; Venous Thrombosis	2022
Perioperative Coagulation Profile in Major Liver Resection for Cancer: A Prospective Observational Study. Thrombosis and haemostasis, 2022, Volume: 122, Issue:10 Topics: Anticoagulants; Antithrombins; Blood Coagulation Factors; Blood Coagulation Tests; Fibrinogen; Hepatectomy; Humans; Liver; Neoplasms; Protein C; Thrombin; Venous Thromboembolism; von Willebrand Factor	2022
Lower-leg injury and knee arthroscopy have distinct effects on coagulation. Blood advances, 2022, 09-13, Volume: 6, Issue:17 Topics: Arthroscopy; Fibrinogen; Humans; Interleukin-6; Leg Injuries; Thrombosis; Venous Thromboembolism; von Willebrand Factor	2022
Major hemorrhage and mortality in COVID-19 patients on therapeutic anticoagulation for venous thromboembolism. Journal of thrombosis and thrombolysis, 2022, Volume: 54, Issue:3 Topics: Anticoagulants; COVID-19; COVID-19 Drug Treatment; Fibrinogen; Hemorrhage; Heparin; Heparin, Low-Molecular-Weight; Humans; Pulmonary Embolism; Venous Thromboembolism	2022
A survey on thromboprophylaxis and coagulation assessment in children and young adults with acute lymphoblastic leukaemia (ALL) in the Nordic and Baltic countries: Different practices of assessment and management. British journal of haematology, 2022, Volume: 199, Issue:1 Topics: Anticoagulants; Antithrombins; Blood Coagulation Disorders; Child; Fibrinogen; Heparin, Low-Molecular-Weight; Humans; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Venous Thromboembolism; Young Adult	2022
The association between autoantibodies and risk for venous thromboembolic events among patients with rheumatoid arthritis. Rheumatology (Oxford, England), 2023, 06-01, Volume: 62, Issue:6 Topics: Arthritis, Rheumatoid; Autoantibodies; Fibrinogen; Humans; Immunoglobulin Isotypes; Immunoglobulin M; Peptides, Cyclic; Rheumatoid Factor; Venous Thromboembolism; Venous Thrombosis	2023
[Functional state of a solitary kidney after nephrectomy for renal cancer]. Urologiia (Moscow, Russia : 1999), 2022, Issue:5 Topics: Aged; Anticoagulants; Carcinoma, Renal Cell; Female; Fibrin; Fibrinogen; Glomerular Filtration Rate; Humans; Kidney; Kidney Neoplasms; Microcirculation; Middle Aged; Nephrectomy; Renal Insufficiency, Chronic; Retrospective Studies; Solitary Kidney; Venous Thromboembolism	2022
Coagulation parameters correlate to venous thromboembolism occurrence during the perioperative period in patients with spinal fractures. Journal of orthopaedic surgery and research, 2023, Dec-06, Volume: 18, Issue:1 Topics: Fibrin Fibrinogen Degradation Products; Fibrinogen; Humans; Infant; Perioperative Period; Retrospective Studies; Risk Factors; Spinal Cord Injuries; Spinal Fractures; Venous Thromboembolism	2023
Fibrinogen gamma gene Haematologica, 2020, Volume: 105, Issue:7 Topics: Alleles; Fibrinogen; Humans; Incidence; Neoplasms; Risk Factors; Venous Thromboembolism	2020
Thrombotic events in SARS-CoV-2 patients: an urgent call for ultrasound screening. Intensive care medicine, 2020, Volume: 46, Issue:6 Topics: Aged; Anticoagulants; Betacoronavirus; Biomarkers; Body Mass Index; C-Reactive Protein; Catheterization, Central Venous; Coronavirus Infections; COVID-19; Cytokine Release Syndrome; Female; Fibrinogen; Health Services Needs and Demand; Humans; Italy; Male; Middle Aged; Pandemics; Pneumonia, Viral; SARS-CoV-2; Ultrasonography; Venous Thromboembolism	2020
Prognostic value of plasma fibrinogen and D-dimer levels in patients with surgically resected non-small cell lung cancer. Surgery today, 2020, Volume: 50, Issue:11 Topics: Aged; Biomarkers, Tumor; Blood Coagulation Disorders; Carcinoma, Non-Small-Cell Lung; Disease-Free Survival; Female; Fibrin Fibrinogen Degradation Products; Fibrinogen; Fibrinolysis; Humans; Lung Neoplasms; Male; Pneumonectomy; Preoperative Period; Prognosis; Survival Rate; Thrombophilia; Venous Thromboembolism	2020
Von Willebrand factor (vWF): marker of endothelial damage and thrombotic risk in COVID-19? Clinical medicine (London, England), 2020, Volume: 20, Issue:5 Topics: Biomarkers; Cohort Studies; Coronavirus Infections; COVID-19; Endothelium, Vascular; Female; Fibrin Fibrinogen Degradation Products; Fibrinogen; Hospital Mortality; Hospitals, University; Humans; Intensive Care Units; Male; Pandemics; Pneumonia, Viral; Risk Assessment; Sampling Studies; Severe Acute Respiratory Syndrome; Survival Rate; United Kingdom; Venous Thromboembolism; von Willebrand Factor	2020
VTE in ICU Patients With COVID-19. Chest, 2020, Volume: 158, Issue:5 Topics: Adult; Aged; Anticoagulants; Betacoronavirus; C-Reactive Protein; Computed Tomography Angiography; Coronavirus Infections; COVID-19; Enoxaparin; Female; Ferritins; Fibrin Fibrinogen Degradation Products; Fibrinogen; Heparin; Humans; Incidence; Intensive Care Units; L-Lactate Dehydrogenase; Male; Middle Aged; Pandemics; Partial Thromboplastin Time; Pneumonia, Viral; Prothrombin Time; Pulmonary Embolism; SARS-CoV-2; Severity of Illness Index; Ultrasonography; Venous Thromboembolism; Venous Thrombosis	2020
Imbalance between procoagulant factors and natural coagulation inhibitors contributes to hypercoagulability in the critically ill COVID-19 patient: clinical implications. European review for medical and pharmacological sciences, 2020, Volume: 24, Issue:17 Topics: Aged; Area Under Curve; Betacoronavirus; Blood Coagulation Factor Inhibitors; Blood Coagulation Factors; Body Mass Index; Coronavirus Infections; COVID-19; Critical Illness; Factor V; Factor VIII; Female; Fibrin Fibrinogen Degradation Products; Fibrinogen; Humans; Male; Middle Aged; Pandemics; Pneumonia, Viral; Protein C; Protein S; ROC Curve; SARS-CoV-2; Venous Thromboembolism	2020
Hemostatic factors, inflammatory markers, and risk of incident venous thromboembolism: The Multi-Ethnic Study of Atherosclerosis. Journal of thrombosis and haemostasis : JTH, 2021, Volume: 19, Issue:7 Topics: Atherosclerosis; Biomarkers; Ethnicity; Fibrinogen; Hemostatics; Humans; Prospective Studies; Risk Factors; Venous Thromboembolism	2021
A Comparison of Thrombosis and Hemorrhage Rates in Patients With Severe Respiratory Failure Due to Coronavirus Disease 2019 and Influenza Requiring Extracorporeal Membrane Oxygenation. Critical care medicine, 2021, 07-01, Volume: 49, Issue:7 Topics: Adult; C-Reactive Protein; Computed Tomography Angiography; COVID-19; Extracorporeal Membrane Oxygenation; Female; Fibrin Fibrinogen Degradation Products; Fibrinogen; Humans; Influenza A virus; Influenza A Virus, H1N1 Subtype; Influenza B virus; Influenza, Human; Intracranial Hemorrhages; London; Male; Middle Aged; Pulmonary Embolism; Retrospective Studies; SARS-CoV-2; State Medicine; Tertiary Care Centers; Ultrasonography, Doppler; Venous Thromboembolism; Venous Thrombosis	2021
Influence of type 2 diabetes mellitus on Khorana venous thromboembolism risk in colorectal cancer patients. Revista espanola de enfermedades digestivas, 2017, Volume: 109, Issue:7 Topics: Adult; Aged; Aged, 80 and over; China; Colorectal Neoplasms; Diabetes Mellitus, Type 2; Female; Fibrinogen; Humans; Male; Middle Aged; Risk; Risk Assessment; Venous Thromboembolism	2017
The venous thromboembolic risk and the clot wave analysis: a useful relationship? Clinical chemistry and laboratory medicine, 2018, 02-23, Volume: 56, Issue:3 Topics: Adolescent; Adult; Aged; Aged, 80 and over; Blood Coagulation Tests; Female; Fibrinogen; Humans; Male; Middle Aged; Risk Factors; Venous Thromboembolism; Young Adult	2018
Joint effects of prothrombotic genotypes and body height on the risk of venous thromboembolism: the Tromsø study. Journal of thrombosis and haemostasis : JTH, 2018, Volume: 16, Issue:1 Topics: ABO Blood-Group System; Aged; Body Height; Case-Control Studies; Factor IX; Factor V; Female; Fibrinogen; Genetic Predisposition to Disease; Humans; Incidence; Male; Middle Aged; Norway; Phenotype; Polymorphism, Single Nucleotide; Prospective Studies; Prothrombin; Risk Assessment; Risk Factors; Venous Thromboembolism	2018
Venous thromboembolism risk associated with ABO, F11 and FGG loci. Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis, 2018, Volume: 29, Issue:6 Topics: Adolescent; Adult; Factor XI; Female; Fibrinogen; Genetic Loci; Genetic Predisposition to Disease; Genotype; Humans; Male; Middle Aged; Polymorphism, Single Nucleotide; Portugal; Venous Thromboembolism; Young Adult	2018
The utility of viscoelastic methods in the prevention and treatment of bleeding and hospital-associated venous thromboembolism in perioperative care: guidance from the SSC of the ISTH. Journal of thrombosis and haemostasis : JTH, 2018, Volume: 16, Issue:11 Topics: Anticoagulants; Blood Coagulation; Cardiology; Elasticity; Fibrinogen; Hemorrhage; Hemostasis; Hospitalization; Humans; Perioperative Care; Perioperative Period; Practice Guidelines as Topic; Venous Thromboembolism; Viscosity	2018
Risk assessment and management of preoperative venous thromboembolism following femoral neck fracture. Journal of orthopaedic surgery and research, 2018, Nov-20, Volume: 13, Issue:1 Topics: Aged; Aged, 80 and over; Case-Control Studies; Disease Management; Female; Femoral Neck Fractures; Fibrin Fibrinogen Degradation Products; Fibrinogen; Humans; Male; Preoperative Care; Retrospective Studies; Risk Assessment; Venous Thromboembolism	2018
Impact of prothrombotic genotypes on the association between family history of myocardial infarction and venous thromboembolism. Journal of thrombosis and haemostasis : JTH, 2019, Volume: 17, Issue:8 Topics: ABO Blood-Group System; Adult; Aged; Case-Control Studies; Factor V; Female; Fibrinogen; Genetic Predisposition to Disease; Humans; Incidence; Male; Middle Aged; Myocardial Infarction; Norway; Pedigree; Polymorphism, Single Nucleotide; Prothrombin; Risk Assessment; Risk Factors; Venous Thromboembolism	2019
Obesity and thrombin-generation profiles in women with venous thromboembolism. Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis, 2013, Volume: 24, Issue:5 Topics: Adolescent; Adult; Aged; Body Mass Index; C-Reactive Protein; Cohort Studies; Cross-Sectional Studies; Female; Fibrinogen; Humans; Inflammation; Middle Aged; Obesity; Plasminogen Activator Inhibitor 1; Prospective Studies; Sweden; Thrombin; Venous Thromboembolism	2013
Primary antiphospholipid antibody syndrome-one further aspect of thrombophilia in overweight and obese patients with venous thromboembolism. Obesity (Silver Spring, Md.), 2013, Volume: 21, Issue:9 Topics: Adult; Aged; Antibodies, Antiphospholipid; Antiphospholipid Syndrome; Body Mass Index; Body Weight; Female; Fibrinogen; Humans; Inflammation; Male; Middle Aged; Obesity; Overweight; Retrospective Studies; Risk Factors; Thrombophilia; Venous Thromboembolism	2013
Venous thromboembolism and prothrombotic parameters in Klippel-Trenaunay syndrome. The Netherlands journal of medicine, 2013, Volume: 71, Issue:5 Topics: Adolescent; Adult; Aged; Case-Control Studies; Child; Child, Preschool; Cohort Studies; Female; Fibrin Fibrinogen Degradation Products; Fibrinogen; Humans; Infant; Klippel-Trenaunay-Weber Syndrome; Magnetic Resonance Imaging; Male; Middle Aged; Peptide Fragments; Prothrombin; Pulmonary Embolism; Ultrasonography, Doppler, Duplex; Venous Thromboembolism; Venous Thrombosis; Young Adult	2013
[Dynamic changes of inflammation-related indices in venous thromboembolism and the association between these indices and venous thromboembolism]. Zhonghua yi xue za zhi, 2013, Jun-25, Volume: 93, Issue:24 Topics: Adolescent; Adult; Aged; Aged, 80 and over; Blood Sedimentation; C-Reactive Protein; Female; Fibrinogen; Humans; Inflammation; Male; Middle Aged; Neutrophils; Risk Factors; Venous Thromboembolism; Young Adult	2013
Patients with antineutrophil cytoplasmic antibodies associated vasculitis in remission are hypercoagulable. The Journal of rheumatology, 2013, Volume: 40, Issue:12 Topics: Adult; Aged; Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis; Antibodies, Antineutrophil Cytoplasmic; Factor VIII; Female; Fibrin Fibrinogen Degradation Products; Fibrinogen; Follow-Up Studies; Humans; Lipoproteins; Male; Middle Aged; Protein C; Protein S; Remission Induction; Risk Factors; Thrombin; Thrombophilia; Venous Thromboembolism	2013
Clinical and Prognostic Significance of Coagulation Assays in Pancreatic Cancer Patients With Absence of Venous Thromboembolism. American journal of clinical oncology, 2015, Volume: 38, Issue:6 Topics: Adult; Aged; Aged, 80 and over; Antithrombin III; Blood Coagulation Tests; Carcinoma, Pancreatic Ductal; Case-Control Studies; Cohort Studies; Disease Progression; Factor VIII; Female; Fibrin Fibrinogen Degradation Products; Fibrinogen; Follow-Up Studies; Humans; International Normalized Ratio; Male; Middle Aged; Neoplasm Metastasis; Pancreatic Neoplasms; Partial Thromboplastin Time; Prognosis; Proportional Hazards Models; Protein C; Prothrombin Time; Retrospective Studies; Venous Thromboembolism	2015
D-dimer use for deep venous thrombosis exclusion in elderly patients: a comparative analysis of three different approaches to establish cut-off values for an assay with results expressed in D-dimer units. International journal of laboratory hematology, 2014, Volume: 36, Issue:5 Topics: Age Factors; Aged; Aged, 80 and over; Biological Assay; Female; Fibrin Fibrinogen Degradation Products; Fibrinogen; Follow-Up Studies; Humans; Male; Middle Aged; Reference Values; Venous Thromboembolism; Venous Thrombosis	2014
Elevated fibrin-related markers in patients with malignant diseases frequently associated with disseminated intravascular coagulation and venous thromboembolism. Internal medicine (Tokyo, Japan), 2014, Volume: 53, Issue:5 Topics: Adult; Aged; Biomarkers, Tumor; Disseminated Intravascular Coagulation; Female; Fibrin; Fibrin Fibrinogen Degradation Products; Fibrinogen; Follow-Up Studies; Humans; Incidence; Japan; Male; Middle Aged; Neoplasms; Retrospective Studies; Risk Factors; ROC Curve; Venous Thromboembolism	2014
High factor VIII, von Willebrand factor, and fibrinogen levels and risk of venous thromboembolism in blacks and whites. Ethnicity & disease, 2014,Spring, Volume: 24, Issue:2 Topics: Black People; Case-Control Studies; Factor VIII; Female; Fibrinogen; Humans; Male; Middle Aged; Risk Factors; United States; Venous Thromboembolism; von Willebrand Factor; White People	2014
Pretreatment plasma D-dimer, fibrinogen, and platelet levels significantly impact prognosis in patients with epithelial ovarian cancer independently of venous thromboembolism. International journal of gynecological cancer : official journal of the International Gynecological Cancer Society, 2015, Volume: 25, Issue:1 Topics: Adult; Aged; Aged, 80 and over; Blood Platelets; Cystadenocarcinoma, Serous; Disease Progression; Female; Fibrin Fibrinogen Degradation Products; Fibrinogen; Follow-Up Studies; Humans; Middle Aged; Neoplasm Grading; Neoplasm Staging; Neoplasm, Residual; Ovarian Neoplasms; Prevalence; Prognosis; Survival Rate; Venous Thromboembolism	2015
Single nucleotide polymorphisms in interleukin-6 and their association with venous thromboembolism. Molecular medicine reports, 2015, Volume: 11, Issue:6 Topics: Adult; Aged; Alleles; C-Reactive Protein; Case-Control Studies; Ethnicity; Female; Fibrin Fibrinogen Degradation Products; Fibrinogen; Genotype; Humans; Interleukin-6; Leptin; Logistic Models; Male; Middle Aged; Plasminogen Activator Inhibitor 1; Polymorphism, Single Nucleotide; Promoter Regions, Genetic; Risk Factors; Venous Thromboembolism	2015
International survey on D-dimer test reporting: a call for standardization. Seminars in thrombosis and hemostasis, 2015, Volume: 41, Issue:3 Topics: Blood Chemical Analysis; Fibrin Fibrinogen Degradation Products; Fibrinogen; Humans; International Cooperation; Reproducibility of Results; Surveys and Questionnaires; Thrombosis; United States; Venous Thromboembolism	2015
Application of ROTEM to assess hypercoagulability in patients with lung cancer. Thrombosis research, 2015, Volume: 135, Issue:6 Topics: Aged; Anticoagulants; Blood Coagulation; Blood Coagulation Tests; Case-Control Studies; Female; Fibrinogen; Hemostasis; Humans; Lung Neoplasms; Male; Middle Aged; Plasminogen Activator Inhibitor 1; Risk Assessment; Thrombelastography; Thrombophilia; Treatment Outcome; Venous Thromboembolism	2015
Incidence of and risk factors for venous thromboembolism during surgical treatment for esophageal cancer: a single-institution study. Surgery today, 2016, Volume: 46, Issue:4 Topics: Adenocarcinoma; Adult; Aged; Aged, 80 and over; C-Reactive Protein; Central Venous Catheters; Esophageal Neoplasms; Female; Fibrinogen; Humans; Incidence; Intraoperative Complications; Japan; Logistic Models; Male; Middle Aged; Neck Dissection; Retrospective Studies; Risk Factors; Venous Thromboembolism	2016
Exome Sequencing and Clot Lysis Experiments Demonstrate the R458C Mutation of the Alpha Chain of Fibrinogen to be Associated with Impaired Fibrinolysis in a Family with Thrombophilia. Journal of atherosclerosis and thrombosis, 2016, Volume: 23, Issue:4 Topics: Blood Coagulation; Blood Coagulation Tests; Exome; Family Health; Female; Fibrin; Fibrinogen; Humans; Male; Mutation; Pedigree; Sequence Analysis, DNA; Thrombin; Thrombophilia; Thrombosis; Venous Thromboembolism	2016
Longitudinal analysis of hemostasis biomarkers in cancer patients during antitumor treatment. Journal of thrombosis and haemostasis : JTH, 2016, Volume: 14, Issue:2 Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Agents; Biomarkers; Factor VIII; Female; Fibrin Fibrinogen Degradation Products; Fibrinogen; Hemostasis; Humans; Longitudinal Studies; Male; Middle Aged; Neoplasms; P-Selectin; Peptide Fragments; Predictive Value of Tests; Proportional Hazards Models; Prospective Studies; Prothrombin; Risk Assessment; Risk Factors; Thrombin; Time Factors; Treatment Outcome; Venous Thromboembolism; Young Adult	2016
Recurrent VTE in a heterozygote of the fibrinogen Aα IVS4+1G>T and Aα p.Arg168Ter mutation. Thrombosis and haemostasis, 2016, 05-02, Volume: 115, Issue:5 Topics: Adolescent; Afibrinogenemia; Anticoagulants; Female; Fibrinogen; Fibrinogens, Abnormal; Hemorrhage; Heterozygote; Humans; Mutation; Recurrence; Venous Thromboembolism	2016
Incidence and risk factors for deep venous thrombosis and pulmonary embolus after liver transplantation. American journal of surgery, 2016, Volume: 211, Issue:4 Topics: Comorbidity; Factor VIII; Female; Fibrinogen; Humans; Incidence; International Normalized Ratio; Liver Transplantation; Male; Middle Aged; Plasma; Postoperative Complications; Pulmonary Embolism; Retrospective Studies; Risk Factors; Venous Thromboembolism	2016
Fibrin-related markers for diagnosing acute-, subclinical-, and pre-venous thromboembolism in patients with major orthopedic surgery. International journal of hematology, 2016, Volume: 103, Issue:5 Topics: Acute Disease; Aged; Biomarkers; Female; Fibrin; Fibrin Fibrinogen Degradation Products; Fibrinogen; Humans; Male; Middle Aged; Orthopedic Procedures; Venous Thromboembolism; Young Adult	2016
Prospective study of γ' fibrinogen and incident venous thromboembolism: The Longitudinal Investigation of Thromboembolism Etiology (LITE). Thrombosis research, 2016, Volume: 139 Topics: Aged; Female; Fibrinogen; Fibrinogens, Abnormal; Humans; Longitudinal Studies; Male; Middle Aged; Polymorphism, Single Nucleotide; Prospective Studies; Risk Factors; United States; Venous Thromboembolism	2016
[Determinants of the elevated factor VIII activity in patients following venous thromboembolism]. Przeglad lekarski, 2016, Volume: 73, Issue:4 Topics: Adolescent; Adult; Age Factors; Aged; Bilirubin; Blood Coagulation; C-Reactive Protein; Factor VIII; Female; Fibrinogen; Hemoglobins; Humans; Male; Middle Aged; Obesity; Venous Thromboembolism; Young Adult	2016
Investigation on genetic thrombophilic factors in FFPE autopsy tissue from subjects who died from pulmonary embolism. International journal of legal medicine, 2017, Volume: 131, Issue:2 Topics: Adult; Aged; Aged, 80 and over; Case-Control Studies; Factor V; Factor XIII; Female; Fibrinogen; Formaldehyde; Genetic Predisposition to Disease; Glucuronidase; Heterozygote; Humans; Lipoproteins; Male; Methylenetetrahydrofolate Reductase (NADPH2); Middle Aged; Paraffin Embedding; Plasminogen Activator Inhibitor 1; Polymerase Chain Reaction; Polymorphism, Genetic; Prothrombin; Pulmonary Embolism; Thrombophilia; Venous Thromboembolism	2017
The Evaluation of Fibrin-Related Markers for Diagnosing or Predicting Acute or Subclinical Venous Thromboembolism in Patients Undergoing Major Orthopedic Surgery. Clinical and applied thrombosis/hemostasis : official journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis, 2018, Volume: 24, Issue:1 Topics: Acute Disease; Aged; Biomarkers; Female; Fibrin Fibrinogen Degradation Products; Fibrinogen; Humans; Male; Middle Aged; Orthopedic Procedures; Postoperative Complications; Venous Thromboembolism	2018
Analysis of the venous thromboembolic risk associated with severe postpartum haemorrhage in the NOHA First cohort. Thrombosis and haemostasis, 2008, Volume: 100, Issue:5 Topics: Adult; Cohort Studies; Erythrocyte Transfusion; Female; Fibrinogen; Hemostatics; Humans; Platelet Transfusion; Postpartum Hemorrhage; Pregnancy; Risk Assessment; Risk Factors; Severity of Illness Index; Venous Thromboembolism; Venous Thrombosis; Young Adult	2008
Metabolic syndrome and risk of venous thromboembolism: Longitudinal Investigation of Thromboembolism Etiology. Journal of thrombosis and haemostasis : JTH, 2009, Volume: 7, Issue:5 Topics: Blood Coagulation Factors; Blood Glucose; Blood Pressure; Body Mass Index; Cohort Studies; Female; Fibrinogen; Humans; Lipids; Longitudinal Studies; Male; Metabolic Syndrome; Proportional Hazards Models; Risk Factors; Venous Thromboembolism	2009
Altered fibrin clot structure/function in patients with idiopathic venous thromboembolism and in their relatives. Blood, 2009, Nov-05, Volume: 114, Issue:19 Topics: Adolescent; Adult; Aged; Blood Coagulation; Blood Coagulation Tests; Case-Control Studies; Factor XIII; Female; Fibrin; Fibrinogen; Fibrinolysis; Genotype; Humans; In Vitro Techniques; Male; Middle Aged; Nephelometry and Turbidimetry; Pulmonary Embolism; Risk Factors; Venous Thromboembolism; Young Adult	2009
Cardiovascular risk factors in idiopathic compared to risk-associated venous thromboembolism: A focus on fibrinogen, factor VIII, and high-sensitivity C-reactive protein (hs-CRP). Thrombosis and haemostasis, 2009, Volume: 102, Issue:4 Topics: Adolescent; Adult; Aged; Blood Coagulation; C-Reactive Protein; Cohort Studies; Factor VIII; Female; Fibrinogen; Follow-Up Studies; Humans; Male; Middle Aged; Risk Factors; Venous Thromboembolism	2009
Rivaroxaban differentially influences ex vivo global coagulation assays based on the administration time. Thrombosis and haemostasis, 2011, Volume: 106, Issue:1 Topics: Aged; Anticoagulants; Antithrombins; Blood Coagulation; Blood Coagulation Tests; Clinical Protocols; Drug Interactions; Factor Xa Inhibitors; Female; Fibrinogen; Humans; Male; Middle Aged; Morpholines; Orthopedic Procedures; Postoperative Complications; Rivaroxaban; Thiophenes; Time Factors; Venous Thromboembolism	2011
The role of fibrinogen plasma levels, the -455G>A fibrinogen and the factor XIII A subunit (FXIII-A) Val34Leu polymorphism in cancer-associated venous thrombosis. Thrombosis and haemostasis, 2011, Volume: 106, Issue:5 Topics: Aged; Analysis of Variance; Austria; Biomarkers; Blood Coagulation; Factor XIII; Female; Fibrinogen; Genetic Predisposition to Disease; Humans; Kaplan-Meier Estimate; Male; Middle Aged; Neoplasms; Phenotype; Polymerase Chain Reaction; Polymorphism, Single Nucleotide; Proportional Hazards Models; Prospective Studies; Risk Assessment; Risk Factors; Time Factors; Venous Thromboembolism	2011
Nitrated fibrinogen is a biomarker of oxidative stress in venous thromboembolism. Free radical biology & medicine, 2012, Jul-15, Volume: 53, Issue:2 Topics: Adult; Aged; Analysis of Variance; Biomarkers; Female; Fibrin Fibrinogen Degradation Products; Fibrinogen; Humans; Inflammation; Male; Middle Aged; Nitrates; Nitrogen Oxides; Oxidative Stress; Prospective Studies; Risk Factors; Venous Thromboembolism	2012
The association of alpha-fibrinogen Thr312Ala polymorphism and venous thromboembolism in the LITE study. Thrombosis research, 2007, Volume: 121, Issue:1 Topics: Aged; Black People; Case-Control Studies; Female; Fibrinogen; Genotype; Humans; Logistic Models; Male; Middle Aged; Mutation, Missense; Polymorphism, Genetic; Venous Thromboembolism; White People	2007
Fibrinogen Aalpha-Thr312Ala and factor XIII-A Val34Leu polymorphisms in idiopathic venous thromboembolism. Thrombosis research, 2007, Volume: 121, Issue:3 Topics: Aged; Aged, 80 and over; Alleles; Amino Acid Substitution; Case-Control Studies; Factor V; Factor XIIIa; Female; Fibrinogen; Humans; Male; Middle Aged; Point Mutation; Polymorphism, Genetic; Pulmonary Embolism; Risk Factors; Venous Thromboembolism	2007
Orthostatic hypercoagulability: a novel physiological mechanism to activate the coagulation system. Hypertension (Dallas, Tex. : 1979), 2008, Volume: 51, Issue:6 Topics: Adult; Blood Coagulation; Blood Pressure; Endothelium, Vascular; Factor V; Factor VIII; Female; Fibrinogen; Hematocrit; Humans; Male; Peptide Fragments; Plasma Volume; Posture; Protein C; Protein Precursors; Prothrombin; Thrombophilia; Thromboplastin; Venous Thromboembolism; von Willebrand Factor	2008